We found that ITGAL was enriched in the mesenchyme in NSCLC tumor tissues, while ITGAL-expressing regions in tumor tissues were accompanied by immune cell aggregation and high expression of immune cell markers. The gene discussed is ITGAL; the disease is non-small cell lung carcinoma.